Answer to Question 1
Correct Answer: 2
Rationale 1: Niacin does not prevent peripheral neuropathy.
Rationale 2: Pyridoxine prevents peripheral neuropathy.
Rationale 3: Cyanocobalamin does not prevent peripheral neuropathy.
Rationale 4: Neurontin does not prevent neuropathy.
Global Rationale: Pregnant patients should receive isoniazid therapy supplemented with pyridoxine (vitamin B6), which has been shown to prevent peripheral neuropathy. The other drugs do not have this action.
Answer to Question 2
Correct Answer: 1,4
Rationale 1: The initial phase of therapy includes 2 months of daily therapy with isoniazid.
Rationale 2: The initial phase of therapy does not include 9 months of ethambutol therapy.
Rationale 3: The initial phase of therapy does not include 4 months of daily ethamubutol therapy.
Rationale 4: The initial phase of therapy includes 2 months of daily therapy with rifampin.
Rationale 5: The initial phase of therapy does not include pyrazinamide two to three times a week for 4 months.
Global Rationale: Initial treatment includes two months of daily therapy with isoniazid, rifampin (Rifadin, Rimactane), pyrazinamide (PZA), and ethambutol (Myambutol). If C&S results show that the strain is sensitive to the first three drugs, ethambutol is dropped from the regimen
Nurse-patient interaction; nonveral communication
Client on IV patient-controlled analgesia (PCA).
A nurse administers an intermittent bolus feeding.
Conditions Treated by Physical Therapy
Wrap the client securely with sheets. (A) Lay one side of the sheet over the body. (B) Enclose the ...
Client and therapist positioning for foot reflexology.